Here, we discuss potential mechanisms and recent data of PGRN pro-inflammatory actions, regarding obesity, insulin resistance, type 2 diabetes mellitus and kidney disease. This evidence concerns the gene GRN and obesity due to melanocortin 4 receptor deficiency.